immunocompromised T-SPOT.TB test females

Reliable in the immunocompromised

Who are the immunocompromised?

Many diagnosed with an underlying condition don’t realize that they are immunocompromised.1 Those with compromised immune systems face a higher risk of contracting tuberculosis (TB) and a higher risk of latent tuberculosis infection (LTBI) becoming active. The Centers for Disease Control and Prevention (CDC) has published the following list of people at high-risk for developing active TB disease once infected with Mycobacterium tuberculosis (MTB):2,3

thumbnail preview
0

Persons living with diabetes

34,200,000 people live with diabetes4

thumbnail preview
0

Persons living with Crohn’s disease or other inflammatory bowel disease

3,000,000 people live with Crohn’s disease or other inflammatory bowel disease5

thumbnail preview
0

Persons living with rheumatoid arthritis

1,500,000 people live with rheumatoid arthritis6

thumbnail preview
0

Persons living with HIV/AIDS

1,100,000 people live with HIV/AIDS7

thumbnail preview
0

Persons living with chronic kidney disease

37,000,000 people live with chronic kidney disease8

  • Persons who are receiving immunosuppressive therapy
  • Persons who were recently infected with MTB (within the past 2 years)
  • Persons with a history of untreated or inadequately treated active TB disease
  • Persons living with leukemia, lymphoma or cancer of the head, neck or lung
  • Persons who have had a gastrectomy or jejunoileal bypass
  • Persons who weigh less than 90% of their ideal body weight
  • Persons who smoke cigarettes or abuse drugs or alcohol
  • Populations defined locally as having an increased incidence of active TB disease, possibly including medically underserved or low-income populations

The T-SPOT.TB test is the only IGRA without a warning or limitation in their package insert for screening immunocompromised individuals13,14

The reliability of the T-SPOT.TB test design, which includes washing and standardizing the number of cells in each patient specimen, is supported by clinical data obtained even in challenging patient populations. The cell enumeration technology in the proprietary T-SPOT.TB test therefore will allow clinicians to confidently screen and detect TB infection.13

Patient populations can vary, but your TB test results should not. The T-SPOT.TB test is accurate across patient populations. In fact, the T-SPOT.TB test is the only TB test without a warning against use in the immunocompromised in the package insert.

  1. Accurate across patient populations13

    • Immunocompromised
    • BCG-vaccinated
  2. Highest sensitivity and specificity compared to other IGRAs

    • Sensitivity: 98.8%
    • Specificity: 100%
  3. US-FDA approved borderline zone provides increased test resolution for results around the cut-off point15,16

Learn more about the
T-SPOT.TB test

Contact Us